-transparent.png){kind=logo}
A 70 year old male patient admitted for coronary bypass surgery presented with a procainamide-induced lupus syndrome. This syndrome included a LLAC with a positive IgM ACA titer as well as a factor XII inhibitor. These drug-induced inhibitors were superimposed upon the patient's congenital deficiency of factor XI. The methods used to identify these abnormalities are described together with the replacement therapy employed to cover the surgical procedure. The long-term withdrawal of procainamide was associated with correction of all coagulation abnormalities except the factor XI deficiency.
Related Publications
L P Clyne, and
L R Farber, and
R L Chopyk
August 1981,
Thrombosis and haemostasis,
L P Clyne, and
L R Farber, and
R L Chopyk
December 1987,
American journal of hematology,
L P Clyne, and
L R Farber, and
R L Chopyk
July 1987,
Blood,
L P Clyne, and
L R Farber, and
R L Chopyk
November 1995,
British journal of haematology,
L P Clyne, and
L R Farber, and
R L Chopyk
August 1994,
Blood,
L P Clyne, and
L R Farber, and
R L Chopyk
February 1998,
British journal of haematology,
L P Clyne, and
L R Farber, and
R L Chopyk
February 1988,
Southern medical journal,
L P Clyne, and
L R Farber, and
R L Chopyk
July 1995,
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
L P Clyne, and
L R Farber, and
R L Chopyk
March 1983,
Revista clinica espanola,
L P Clyne, and
L R Farber, and
R L Chopyk
April 2021,
Hamostaseologie,
